BV
Bavarian Nordic A/S
BVNRY · OTC
$10.50 +0.12% (+$0.01)
1M +13.36%
Market Cap 15.6B kr
P/E Ratio 10.04x
Div. Yield -
ROE 12.00%
Bulios Fair Price
$13.22
26.0% upside
Trenutna cena
$10.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BVNRY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
96 /100
Cheap P/E 10.04x
EV/EBITDA 5.68x
P/S 2.57x
Growth
100 /100
Growing Rev. growth 23.49%
Book val. growth 21.64%
EPS growth N/A
Profitability
91 /100
Strong Gross margin 51.72%
Net margin 25.64%
Op. margin 16.57%
Quality
47 /100
Average ROIC 5.67%
ROE 12.00%
ROA 10.58%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 6.53x
Int. coverage 137.78x
Stability
32 /100
Unstable Beta 0.94x
Rev. volatility 76.93%
EPS volatility 285.42%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BVNRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul John Chaplin
Employees
1,795
Headquarters
Hellerup